Detalhe da pesquisa
1.
The small-molecule SMARt751 reverses Mycobacterium tuberculosis resistance to ethionamide in acute and chronic mouse models of tuberculosis.
Sci Transl Med
; 14(643): eaaz6280, 2022 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507672
2.
Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis.
Antimicrob Agents Chemother
; 53(5): 2100-9, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19237648
3.
Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420.
Science
; 355(6330): 1206-1211, 2017 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28302858
4.
Biological evaluation of bisbenzaldehydes against four Mycobacterium species.
Eur J Med Chem
; 63: 731-8, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23567963
5.
BCG induces protection against Mycobacterium tuberculosis infection in the Wistar rat model.
PLoS One
; 6(12): e28082, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22162757
6.
Mycobacterium tuberculosis infection induces hypoxic lung lesions in the rat.
Tuberculosis (Edinb)
; 91(4): 339-41, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21636324
7.
Experimental tuberculosis in the Wistar rat: a model for protective immunity and control of infection.
PLoS One
; 6(4): e18632, 2011 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-21533270